197 related articles for article (PubMed ID: 36614038)
1. Blocking Muscarinic Receptor 3 Attenuates Tumor Growth and Decreases Immunosuppressive and Cholinergic Markers in an Orthotopic Mouse Model of Colorectal Cancer.
Kuol N; Davidson M; Karakkat J; Filippone RT; Veale M; Luwor R; Fraser S; Apostolopoulos V; Nurgali K
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614038
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines.
Kuol N; Godlewski J; Kmiec Z; Vogrin S; Fraser S; Apostolopoulos V; Nurgali K
BMC Cancer; 2023 Oct; 23(1):971. PubMed ID: 37828429
[TBL] [Abstract][Full Text] [Related]
3. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
Song P; Sekhon HS; Lu A; Arredondo J; Sauer D; Gravett C; Mark GP; Grando SA; Spindel ER
Cancer Res; 2007 Apr; 67(8):3936-44. PubMed ID: 17440109
[TBL] [Abstract][Full Text] [Related]
4. Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).
Zhao Q; Gu X; Zhang C; Lu Q; Chen H; Xu L
Cancer Biol Ther; 2015; 16(4):634-43. PubMed ID: 25778781
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation.
Yu H; Xia H; Tang Q; Xu H; Wei G; Chen Y; Dai X; Gong Q; Bi F
Sci Rep; 2017 Jan; 7():40802. PubMed ID: 28102288
[TBL] [Abstract][Full Text] [Related]
6. Activation of M3 muscarinic receptor by acetylcholine promotes non-small cell lung cancer cell proliferation and invasion via EGFR/PI3K/AKT pathway.
Xu R; Shang C; Zhao J; Han Y; Liu J; Chen K; Shi W
Tumour Biol; 2015 Jun; 36(6):4091-100. PubMed ID: 25964092
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation.
Cheng K; Samimi R; Xie G; Shant J; Drachenberg C; Wade M; Davis RJ; Nomikos G; Raufman JP
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G591-7. PubMed ID: 18653726
[TBL] [Abstract][Full Text] [Related]
8. [M3 Muscarnic Receptor Antagonist Mediates Cell Proliferation Apoptosis
and Adhesion in Small Cell Lung Cancer].
Wu W; Zhang S; Hu C
Zhongguo Fei Ai Za Zhi; 2016 Mar; 19(3):113-21. PubMed ID: 27009814
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic type 3 receptor induces cytoprotective signaling in salivary gland cells through epidermal growth factor receptor transactivation.
Kajiya M; Ichimonji I; Min C; Zhu T; Jin JO; Yu Q; Almazrooa SA; Cha S; Kawai T
Mol Pharmacol; 2012 Jul; 82(1):115-24. PubMed ID: 22511543
[TBL] [Abstract][Full Text] [Related]
10. Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma.
Hering NA; Liu V; Kim R; Weixler B; Droeser RA; Arndt M; Pozios I; Beyer K; Kreis ME; Seeliger H
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34203220
[TBL] [Abstract][Full Text] [Related]
11. Activated cholinergic signaling provides a target in squamous cell lung carcinoma.
Song P; Sekhon HS; Fu XW; Maier M; Jia Y; Duan J; Proskosil BJ; Gravett C; Lindstrom J; Mark GP; Saha S; Spindel ER
Cancer Res; 2008 Jun; 68(12):4693-700. PubMed ID: 18559515
[TBL] [Abstract][Full Text] [Related]
12. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
13. Targeting M3 Muscarinic Receptors for Colon Cancer Therapy.
Felton J; Hu S; Raufman JP
Curr Mol Pharmacol; 2018; 11(3):184-190. PubMed ID: 29357811
[TBL] [Abstract][Full Text] [Related]
14. Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer.
Ali O; Tolaymat M; Hu S; Xie G; Raufman JP
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450835
[TBL] [Abstract][Full Text] [Related]
15. R2-8018 reduces the proliferation and migration of non-small cell lung cancer cells by disturbing transactivation between M3R and EGFR.
Lan L; Wang H; Yang R; Liu F; Bi Q; Wang S; Wei X; Yan H; Su R
Life Sci; 2019 Oct; 234():116742. PubMed ID: 31401315
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic Acetylcholine Receptor M3 Expression and Survival in Human Colorectal Carcinoma-An Unexpected Correlation to Guide Future Treatment?
Lobbes LA; Schütze MA; Droeser R; Arndt M; Pozios I; Lauscher JC; Hering NA; Weixler B
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175905
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells.
Xie G; Cheng K; Shant J; Raufman JP
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G755-63. PubMed ID: 19221016
[TBL] [Abstract][Full Text] [Related]
18. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic receptor activation in colon cancer selectively augments pro-proliferative microRNA-21, microRNA-221 and microRNA-222 expression.
Larabee SM; Cheng K; Raufman JP; Hu S
PLoS One; 2022; 17(6):e0269618. PubMed ID: 35657974
[TBL] [Abstract][Full Text] [Related]
20. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.
Said AH; Hu S; Abutaleb A; Watkins T; Cheng K; Chahdi A; Kuppusamy P; Saxena N; Xie G; Raufman JP
Biochem J; 2017 Feb; 474(5):647-665. PubMed ID: 28008134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
